Com­pound­ing drugs dur­ing the pan­dem­ic: FDA of­fers pol­i­cy clar­i­fi­ca­tions

In re­sponse to “many emails from stake­hold­ers,” the FDA late Mon­day clar­i­fied a few poli­cies re­lat­ed to drug com­pound­ing, in­clud­ing one on the lim­it on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.